Victoria Hinder

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas Brand, Alison Tree, Peter Ostler et al. · The Lancet Oncology · 2019 · 519 citations · Full text

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Alison Tree, Peter Ostler, H. van der Voet et al. · The Lancet Oncology · 2022 · 280 citations · Full text

A Multigene Urine Test for the Detection and Stratification of Bladder Cancer in Patients Presenting with Hematuria

P.J. O’Sullivan, Katrina Sharples, Mark E. Dalphin et al. · The Journal of Urology · 2012 · 165 citations

A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients

Olivier Gasser, Katrina Sharples, Catherine Barrow et al. · Cancer Immunology Immunotherapy · 2017 · 56 citations · Full text

Vaccination, Cancer Immunosurveillance, High-risk Melanoma Patients +15

Everolimus and Zoledronic Acid in Patients With Renal Cell Carcinoma With Bone Metastases: A Randomized First-Line Phase II Trial

Reuben Broom, Victoria Hinder, Katrina Sharples et al. · Clinical Genitourinary Cancer · 2014 · 40 citations

Zoledronic Acid, Urology, Surgical Oncology +7